Symposium:
81. Candidiasis 2011
Friday, October 21, 2011: 2:15 PM-4:15 PM
Room: 210ABC

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • relate global epidemiological trends in candidiasis with resistance patterns and geographical variations
  • review the recent developments in molecular diagnosis of candidiasis
  • evaluate accumulating knowledge regarding the activity of novel antifungals against biofilm-embedded Candida
  • review recent data about strategies to combat candidiasis in the ICU

Target Audience: Researchers, Pharmacists, Nurses, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, Hospital Epidemiologists, HIV Clinicians, Health Care Workers, Fellows-in-Training, Epidemiologists, Clinicians, Academicians

Tracks: Investigative ID, Adult ID

Moderators:  Jack D. Sobel, MD, FIDSA, Wayne State University/Detroit Medical Center and Luis Ostrosky-Zeichner, MD, FIDSA, University of Texas Medical School at Houston

Presentations:

2:15 PM
733

3:15 PM
735
Antifungal Lock Therapy
Samuel A. Lee, MD, PhD

3:45 PM
736
New Therapeutic Developments in Candidiasis in the ICU
Luis Ostrosky-Zeichner, MD, FIDSA

CME Credits: Maximum of 2.0 hours of Category 1 credit possible

ACPE Credits: ACPE 2.0 knowledge-based contact hours (0.2 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-153-L01-P

Disclosures:

J. D. Sobel, None

L. Ostrosky-Zeichner, Merck: Consultant, Grant Investigator, Non-branded speaker and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Pfizer: Consultant, Grant Investigator, Non-branded speaker and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Astellas: Scientific Advisor, Consulting fee
Associates of Cape Cod: Grant Investigator, Research grant
GSK: , Speaker honorarium

T. Chiller, None

S. Chen, None

S. A. Lee, Pfizer: Shareholder, Own 240 shares of common stock

L. Ostrosky-Zeichner, Merck: Consultant, Grant Investigator, Non-branded speaker and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Pfizer: Consultant, Grant Investigator, Non-branded speaker and Scientific Advisor, Consulting fee, Research grant and Speaker honorarium
Astellas: Scientific Advisor, Consulting fee
Associates of Cape Cod: Grant Investigator, Research grant
GSK: Non-branded speaker, Speaker honorarium

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.